84 related articles for article (PubMed ID: 24640675)
1. [Markers of endothelial dysfunction (VCAM-1 and vWF) in chronic hepatitis C].
Antonova TV; Romanova MA; Lymar' IuV
Ter Arkh; 2013; 85(12):86-9. PubMed ID: 24640675
[TBL] [Abstract][Full Text] [Related]
2. [Markers of vascular endothelium activation in gout].
Lapkina NA; Baranov AA; Barskova VG; Abaĭtova NE; Iakunina IA
Ter Arkh; 2005; 77(5):62-5. PubMed ID: 15989007
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis.
Zhang Q; Zeng C; Fu Y; Cheng Z; Zhang J; Liu Z
Nephrology (Carlton); 2012 May; 17(4):338-45. PubMed ID: 22295953
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
5. [Endothelial dysfunction in rheumatic patients].
Shilkina NP; Butusova SV
Klin Med (Mosk); 2013; 91(4):58-61. PubMed ID: 23879057
[TBL] [Abstract][Full Text] [Related]
6. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
Boursier J; de Ledinghen V; Zarski JP; Rousselet MC; Sturm N; Foucher J; Leroy V; Fouchard-Hubert I; Bertrais S; Gallois Y; Oberti F; Dib N; Calès P
Am J Gastroenterol; 2011 Jul; 106(7):1255-63. PubMed ID: 21468012
[TBL] [Abstract][Full Text] [Related]
7. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
[TBL] [Abstract][Full Text] [Related]
8. Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C.
Shlomai A; Halfon P; Goldiner I; Zelber-Sagi S; Halpern Z; Oren R; Bruck R
J Viral Hepat; 2013 Feb; 20(2):95-102. PubMed ID: 23301544
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.
Maieron A; Salzl P; Peck-Radosavljevic M; Trauner M; Hametner S; Schöfl R; Ferenci P; Ferlitsch M
Aliment Pharmacol Ther; 2014 Feb; 39(3):331-8. PubMed ID: 24308724
[TBL] [Abstract][Full Text] [Related]
10. [Markers of endothelial activation in rheumatoid arthritis].
Shilikina NP; Yunonin IE; Vinogradov AA; Butusova SV
Ter Arkh; 2012; 84(8):29-32. PubMed ID: 22994085
[TBL] [Abstract][Full Text] [Related]
11. Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood.
Kas-Deelen AM; Harmsen MC; De Maar EF; Oost-Kort WW; Tervaert JW; Van Der Meer J; Van Son WJ; The TH
Kidney Int; 2000 Dec; 58(6):2533-42. PubMed ID: 11115088
[TBL] [Abstract][Full Text] [Related]
12. The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis.
Mackinnon B; Deighan CJ; Norrie J; Boulton-Jones JM; Sattar N; Fox JG
Clin Nephrol; 2005 Mar; 63(3):173-80. PubMed ID: 15786817
[TBL] [Abstract][Full Text] [Related]
13. Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?
de Groot L; Jager NA; Westra J; Smit AJ; Kallenberg CG; Posthumus MD; Bijl M
Rheumatology (Oxford); 2015 Jul; 54(7):1257-61. PubMed ID: 25587178
[TBL] [Abstract][Full Text] [Related]
14. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients.
Pawlak K; Myśliwiec M; Pawlak D
Adv Med Sci; 2010; 55(2):196-203. PubMed ID: 20439183
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum adipocyte fatty acid-binding protein and endothelial/hemostatic markers in dyslipidemic subjects.
Karasek D; Vaverkova H; Frysak Z; Orsag J; Novotny D; Halenka M; Slavik L
Neuro Endocrinol Lett; 2012; 33 Suppl 2():26-31. PubMed ID: 23183506
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal hypertension is associated with an exacerbation of the endothelial damage in preeclampsia.
Bouchlariotou S; Liakopoulos V; Dovas S; Giannopoulou M; Kiropoulos T; Zarogiannis S; Gatselos G; Zachopoulos T; Kyriakou DS; Kallitsaris A; Messinis I; Stefanidis I
Am J Nephrol; 2008; 28(3):424-30. PubMed ID: 18097134
[TBL] [Abstract][Full Text] [Related]
18. [Von Willebrand factor and thrombomodulin as markers of endothelial cell functions in children with chronic viral hepatitis].
Kulwas A; Szaflarska-Szczepanik A; Czerwionka-Szaflarska M; Kotschy M
Med Wieku Rozwoj; 2004; 8(1):107-14. PubMed ID: 15557702
[TBL] [Abstract][Full Text] [Related]
19. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis.
Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V
J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
